Leaman-Alcibar O., Cigarral C. , Déniz C., Romero-Palomar I., Navarro-Martin A.*

Leaman-Alcibar et al. J Clin Transl Res 2021, 7(2):18

Published online: April 22, 2021

Abstract

Background and aim: Health reported quality of life test (HRQOLT) in oncologic patients has become a major concern. Early stage in non-small cell lung cancer (ES-NSCLC) has two options for treatment in fragile population: Stereotactic body radiation therapy (SBRT) and Video assisted thoracic surgery (VATS). Which option should be recommended in daily clinical practice remains a challenging question. The current review is addressing this concern. Among 1256 articles, 19 met the inclusion criteria and 2034 patients were analyzed treated either with VATS or SBRT. Eleven manuscripts in SBRT, five VATS studies and three reviews were summarized in the present review. In fragile population, SBRT seems to be a valuable option of treatment with minor or no changes in HRQOLT. However, baseline quality of life status or geriatric assessment tools before treatment could be a good strategy to select appropriate population for undergoing SBRT or surgery.
Relevance for patients: In this paper, we present a systematic review where we compare the current evidence of two options for treatment in fragile population: Stereotactic body radiation therapy (SBRT) and Video assisted thoracic surgery (VATS).

DOI: http://dx.doi.org/10.18053/jctres.07.202102.018

Author affiliation

1. Department of Radiation Oncology, Gregorio Marañón General University Hospital, Madrid, Spain.
2. Department of Radiation Oncology, Salamanca University Hospital, Spain.
3. Department of Thoracic Surgery. Bellvitge University Hospital. L’Hospitalet (Barcelona), Spain.
4. Gregorio Marañón General University Hospital Library. Madrid, Spain.
5. Department of Radiation Oncology, Catalan Institute of Oncology, L’Hospitalet (Barcelona), Spain.

*Corresponding Author
Arturo Navarro-Martin
Department of Radiation Oncology. Catalan Institute of Oncology. Avda Gran Via 199-203. L’Hospitalet (Barcelona), Spain.
E-mail: anavarro@iconcologia.net

Handeling editor:
Michal Heger
Department of Pharmaceutics, Utrecht University, the Netherlands
Department of Pharmaceutics, Jiaxing University Medical College, Zhejiang, China

Downloads

Full text PDF